Report Code : CVMI160520254 | Published Date : May 16, 2025

The Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market has emerged as a critical segment within the global animal vaccine landscape. With swine diseases threatening herd health and food security worldwide, PRRS has become a focal concern due to its highly infectious nature and economic burden. In 2024, the global PRRS vaccine market is valued at approximately USD 1.05 billion and is projected to reach USD 1.78 billion by 2031, expanding at a CAGR of 7.8%. The market is driven by the rise in PRRS outbreaks, advances in vaccine technologies, and increasing swine production in Asia and Latin America.

 

Key Market Drivers

Rising PRRS Incidence: The resurgence of PRRS variants in North America and Europe has amplified vaccination efforts. In Asia, outbreaks have led to mass culling in several countries, escalating the need for preventive immunization.

Economic Losses & Food Security: PRRS causes reproductive failure, reduced growth performance, and secondary infections. Annual global losses exceed USD 2.5 billion, prompting national disease-control programs and commercial vaccination campaigns.

Biotech Advances: Recombinant and vector-based vaccines are offering improved efficacy and duration of immunity, enabling better control of emerging PRRS virus (PRRSV) strains.

 

Market Segmentation

By Vaccine Type

  • Modified Live Vaccines (60%): Dominant due to their rapid immune response.
  • Inactivated Vaccines (XX%): Preferred in breeding stock and low-infection zones.
  • Recombinant & Subunit Vaccines (XX%): Fast-growing, especially in North America and Europe.

 

By Route of Administration

  • Intramuscular (XX%): Standard for large-scale immunization.
  • Intranasal (XX%): Gaining traction for mucosal immunity.
  • Oral (10%): Emerging in Asia-Pacific for easier mass administration.

 

By Region

  • Asia-Pacific (38%): China and Vietnam driving demand through government-led PRRS control programs.
  • North America (XX%): Strong commercial swine operations and tech adoption.
  • Europe (XX%): Targeted immunization in high-biosecurity farms.
  • Latin America & Others (XX%): Brazil and Mexico ramping up vaccine access.

 

Competitive Landscape

Leading players are investing in next-gen vaccine platforms, thermostable formulations, and variant-specific protection.

  • Boehringer Ingelheim: Ingelvac PRRS MLV line widely used in North America and Europe.
  • Zoetis: Offers both live and killed vaccines, with regional customization.
  • Ceva Animal Health: Strong presence in Asia with thermostable intranasal products.
  • MSD Animal Health: Investing in recombinant PRRS vaccine technologies.
  • Kyoto Biken: Expanding R&D in Asia to address local strain challenges.

 

Emerging Trends

mRNA-Based PRRS Vaccines: Development is underway to replicate the success of human mRNA vaccines in the livestock sector, promising rapid scalability and superior protection.

Thermostable & Needle-Free Options: Innovations in heat-resistant and intranasal vaccines are improving shelf life and ease of delivery, especially in tropical markets.

Autogenous Vaccines: Custom PRRS vaccines tailored to individual farms are gaining attention in Europe and North America, enhancing strain-specific protection.

AI-Based Disease Surveillance: Predictive modeling and digital tools are being used to optimize vaccination timing and assess outbreak risks.

 

Regulatory Landscape

PRRS vaccination policies are evolving rapidly. Several countries are updating their disease reporting and control regulations to mandate PRRS vaccination or subsidize access. Regulatory authorities are fast-tracking novel vaccine approvals in response to rising threat levels.





Reasons To Buy

Image



Scope

Image
  • Zoetis Inc.
  • Boehringer Ingelheim
  • Merck Animal Health
  • Ceva Santé Animale
  • HIPRA
  • Phibro Animal Health Corporation
  • Bioveta, a.s.
  • Indian Immunologicals Limited

 

Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Report

 

  1. 1. Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Research Report - Preface
    1. 2.1 Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Vaccine Type
      2. 2.1.2 By Route of Administration
      3. 2.1.3 By Region
  3. 3. Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Vaccine Type, By Route of Administration, By Country
    3. 3.3. Opportunities – By Vaccine Type, By Route of Administration, By Country
    4. 3.4. Trends – By Vaccine Type, By Route of Administration, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Research Report – DROTs Impact Analysis
    1. 4. Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market, By Vaccine Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Modified Live Vaccines
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Inactivated Vaccines
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Recombinant & Subunit Vaccines
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market, By Route of Administration, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Intramuscular
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Intranasal
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Oral
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 7. Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 North America
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.2 Europe
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.3 Asia-Pacific
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.4 Latin America
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.5 Middle East and Africa
      1. 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.6 Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market - Opportunity Analysis Index, By Vaccine Type, By Route of Administration, and Region, 2024 - 2031
  1. 8. North America Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.1.1 Modified Live Vaccines
      2. 8.1.2 Inactivated Vaccines
      3. 8.1.3 Recombinant & Subunit Vaccines
      8.2 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.2.1 Intramuscular
      2. 8.2.2 Intranasal
      3. 8.2.3 Oral
      8.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.3.1 United States
      2. 8.3.2 Canada
    2. 8.4 North America Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market – Opportunity Analysis Index, By Vaccine Type, By Route of Administration, and Country, 2024 - 2031
    3. 8.5 Regional Trends Analysis
    4. 8.6 North America Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Research Report - Company Profiles
      1. 8.6.1 Company 1 (United States)
      2. 8.6.2 Company 2 (Canada)
      3. 8.6.3 Company 3 (Canada)
    9. Europe Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Modified Live Vaccines
      2. 9.1.2 Inactivated Vaccines
      3. 9.1.3 Recombinant & Subunit Vaccines
      9.2 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Intramuscular
      2. 9.2.2 Intranasal
      3. 9.2.3 Oral
      9.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Germany
      2. 9.3.2 United Kingdom
      3. 9.3.3 France
      4. 9.3.4 Spain
      5. 9.3.5 Italy
      6. 9.3.6 Russia
      7. 9.3.7 Netherlands and Rest of Europe
    2. 9.4 Europe Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market – Opportunity Analysis Index, By Vaccine Type, By Route of Administration, and Country, 2024 - 2031
    3. 9.5 Regional Trends Analysis
    4. 9.6 Europe Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Research Report - Company Profiles
      1. 9.6.1 Company 1 (Germany)
      2. 9.6.2 Company 2 (United Kingdom)
      3. 9.6.3 Company 3 (United Kingdom)
    10. Asia-Pacific Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Modified Live Vaccines
      2. 10.1.2 Inactivated Vaccines
      3. 10.1.3 Recombinant & Subunit Vaccines
      10.2 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Intramuscular
      2. 10.2.2 Intranasal
      3. 10.2.3 Oral
      10.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 China
      2. 10.3.2 Japan
      3. 10.3.3 India
      4. 10.3.4 South Korea
      5. 10.3.5 Australia & New Zealand
      6. 10.3.6 ASEAN
      7. 10.3.7 Rest of Asia-Pacific
    2. 10.4 Asia-Pacific Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market – Opportunity Analysis Index, By Vaccine Type, By Route of Administration, and Country, 2024 - 2031
    3. 10.5 Regional Trends Analysis
    4. 10.6 Asia-Pacific Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Research Report - Company Profiles
      1. 10.6.1 Company 1 (China)
      2. 10.6.2 Company 2 (Japan)
      3. 10.6.3 Company 3 (Japan)
    11. Latin America Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Modified Live Vaccines
      2. 11.1.2 Inactivated Vaccines
      3. 11.1.3 Recombinant & Subunit Vaccines
      11.2 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Intramuscular
      2. 11.2.2 Intranasal
      3. 11.2.3 Oral
      11.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Brazil
      2. 11.3.2 Mexico
      3. 11.3.3 Argentina
      4. 11.3.4 Peru
      5. 11.3.5 Colombia
      6. 11.3.6 Rest of Latin America
    2. 11.4 Latin America Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market – Opportunity Analysis Index, By Vaccine Type, By Route of Administration, and Country, 2024 - 2031
    3. 11.5 Regional Trends Analysis
    4. 11.6 Latin America Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Research Report - Company Profiles
      1. 11.6.1 Company 1 (Brazil)
      2. 11.6.2 Company 2 (Mexico)
      3. 11.6.3 Company 3 (Mexico)
    12. Middle East and Africa Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Modified Live Vaccines
      2. 12.1.2 Inactivated Vaccines
      3. 12.1.3 Recombinant & Subunit Vaccines
      12.2 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Intramuscular
      2. 12.2.2 Intranasal
      3. 12.2.3 Oral
      12.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Saudi Arabia
      2. 12.3.2 UAE
      3. 12.3.3 South Africa
      4. 12.3.4 Egypt
      5. 12.3.5 Israel
      6. 12.3.6 Rest of Middle East and Africa
    2. 12.4 Middle East and Africa Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market – Opportunity Analysis Index, By Vaccine Type, By Route of Administration, and Country, 2024 - 2031
    3. 12.5 Regional Trends Analysis
    4. 12.6 Middle East and Africa Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market Research Report - Company Profiles
      1. 12.6.1 Company 1 (Saudi Arabia)
      2. 12.6.2 Company 2 (UAE)
      3. 12.6.3 Company 3 (UAE)
    13. Competition Landscape
    1. 13.1 Strategic Dashboard of Top Market Players
    2. 13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 13.2.1 Zoetis Inc.
      2. 13.2.2 Boehringer Ingelheim
      3. 13.2.3 Merck Animal Health
      4. 13.2.4 Ceva Santé Animale
      5. 13.2.5 HIPRA
      6. 13.2.6 Phibro Animal Health Corporation
      7. 13.2.7 Bioveta a.s.
      8. 13.2.8 Indian Immunologicals Limited
  1. 14. Data Collection Method and Research Approach
  2. 15. Principal Presumptions and Acronyms